Clinical Significance of Factor XIII Activity and Monocyte-Derived Microparticles in Cancer Patients

被引：7
|
作者：
Sawai, Yusuke [1 ]
Yamanaka, Yuta [1 ]
Nomura, Shosaku [1 ]
机构：
[1] Kansai Med Univ, Dept Internal Med 1, 2-3-1 Shin Machi, Hirakata, Osaka 5731191, Japan
来源：
VASCULAR HEALTH AND RISK MANAGEMENT | 2020年 / 16卷
基金：
日本学术振兴会;
关键词：
factor XIII activity; cancer; thrombosis; endothelial cell; monocyte-derived microparticle; MDMP; MEAN PLATELET VOLUME; TISSUE-FACTOR; COAGULATION-FACTOR; VENOUS THROMBOEMBOLISM; IN-VIVO; RISK; LUNG; THROMBOSIS; RECOMMENDATIONS; DEFICIENCY;
D O I：
10.2147/VHRM.S240500
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
Background: The aim was to evaluate factor XIII activity (FXIIIa) and monocyte-derived microparticles (MDMPs) in cancer patients. Methods: In total, 138 cancer patients (31 malignant lymphomas, 39 multiple myelomas, and 68 lung cancers) were analyzed. We measured various biomarkers including FXIIIa and MDMPs. Results: The values of endothelial activation markers, monocyte chemoattractant peptide (MCP)-1, soluble (s)CD14, and MDMPs were higher in cancer patients than in noncancerous controls. MCP-1, sCD14, and MDMPs were significantly correlated with FXIIIa in multivariate analysis in cancer patients. In addition, MCP-1, sCD14, and MDMP levels were significantly increased in the high FXIIIa group of patients. Finally, the survival rate of the high FXIIIa group was significantly poor in the Kaplan-Meier analysis. Conclusion: These results suggest that abnormal levels of FXIIIa and MDMPs may offer promise as poor prognostic factors in cancer patients.
引用
收藏
页码：103 / 110
页数：8
相关论文
共 50 条
  • [21] Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism
    Campello, Elena
    Spiezia, Luca
    Radu, Claudia M.
    Bulato, Cristiana
    Castelli, Monica
    Gavasso, Sabrina
    Simioni, Paolo
    THROMBOSIS RESEARCH, 2011, 127 (05) : 473 - 477
  • [22] Involvement of monocyte-derived extracellular vesicle-associated tissue factor activity in convallatoxin-induced hypercoagulability
    Morimoto, Mami
    Tatsumi, Kohei
    Takabayashi, Yoko
    Sakata, Asuka
    Yuui, Katsuya
    Terazawa, Ikuko
    Kudo, Risa
    Kasuda, Shogo
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (03) : 184 - 190
  • [23] Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients
    Hernandez, Carmen
    Orbe, Josune
    Roncal, Carmen
    Alvarez-Hernandez, Maria
    Martinez de Lizarrondo, Sara
    Alves, Maria T.
    Garcia Mata, Jesus
    Paramo, Jose A.
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (03) : 598 - 608
  • [24] Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis
    van Es, Nick
    Bleker, Suzanne
    Sturk, Auguste
    Nieuwland, Rienk
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (07) : 718 - 727
  • [25] Enhancement of Tissue Factor Expression in Monocyte-Derived Dendritic Cells by Pentraxin 3 and Its Modulation by C1 Esterase Inhibitor
    Kasuda, Shogo
    Sakurai, Yoshihiko
    Tatsumi, Kohei
    Takeda, Tomohiro
    Kudo, Risa
    Yuui, Katsuya
    Hatake, Katsuhiko
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2019, 179 (02) : 158 - 164
  • [26] Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity
    Leitner, Martina
    Buchold, Christian
    Pasternack, Ralf
    Binder, Nikolaus B.
    Moore, Gary W.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 14
  • [27] Monocyte-derived dendritic cells from patients with cervical intraepithelial lesions
    Lopes, Angela Maria Moed
    Michelin, Marcia Antoniazi
    Murta, Eddie Fernando Candido
    ONCOLOGY LETTERS, 2017, 13 (03) : 1456 - 1462
  • [28] Histophilus somni stimulates bovine monocyte-derived macrophages to release microparticles that increase fibrin clot formation in vitro
    Rivas, Jose J. Rivera
    Czuprynski, Charles J.
    VETERINARY MICROBIOLOGY, 2022, 264
  • [29] Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer
    Kasthuri, Raj S.
    Hisada, Yohei
    Ilich, Anton
    Key, Nigel S.
    Mackman, Nigel
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 636 - 643
  • [30] Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation
    Florian Langer
    Brigitte Spath
    Katja Haubold
    Katharina Holstein
    Guy Marx
    Jan Wierecky
    Tim H. Brümmendorf
    Judith Dierlamm
    Carsten Bokemeyer
    Barbara Eifrig
    Annals of Hematology, 2008, 87 : 451 - 457
12345